Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial fibrillation, allowing it to combine cardiac mapping sensors and therapy delivery ...
Medtronic (MDT) announced FDA approval ... treatment of persistent atrial fibrillation and for RF ablation of cavotricuspid isthmus dependent atrial flutter. With this approval, Medtronic is ...
The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval ... and maintaining normal sinus rhythm. Atrial Fibrillation (AF) is the most common sustained ...
Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback